Cite
HARVARD Citation
Reichardt, P. et al. (2016). Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial. BMC cancer. 16 (1), pp. 1-10. [Online].